June 17, 2021Open Access
Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients With Crohn Disease: Posthoc Analysis of the LOVE-CD Study
Key Points
Key points are not available for this paper at this time.
Abstract
Model-informed dosing of vedolizumab in CD provides a foundation for future research aiming to maximize endoscopic remission rates.
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...
Cite this study
Hanžel et al. (Thu,) studied this question.
synapsesocial.com/papers/69db2bcd5b363cdf1c83585b — DOI: https://doi.org/10.1093/ibd/izab143
Authors
J
Jurij Hanžel
University of Ljubljana
E
Erwin Dreesen
KU Leuven
Séverine Vermeire
KU Leuven
Journals
Inflammatory Bowel Diseases
Actions
Institutions
KU Leuven
Radboud University Nijmegen
Uppsala University
References and Citations
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...